Neuropharmacology and Neurotoxicity of 3,4-Methylenedioxymethamphetamine - Drugs of Abuse: Neurological Reviews and Protocols - page 70

84. Poblete, J. C. and Azmitia, E. C. (1995) Activation of glycogen phosphorylase
by serotonin and 3,4-methylenedioxymethamphetamine in astroglial-rich primary
cultures: involvement of the 5-HT 2A receptor. Brain Res. 680, 9-15.
85. Series, H. G., Masurier, M., Gartside, S., Franklin, M., and Sharp, T. (1995)
Behavioral and neuroendocrine responses to d -fenfl uramine in rats treated with
neurotoxic amphetamines. J. Psychopharmacol. 9, 214-219.
86. Bauman, M. H., Ayestas, M., and Rothman, R. B. (1998) Functional consequences
of central serotonin depletion produced by repeated fenfl uramine administration
to rats. J. Neurosci. 18, 9069-9077.
87. Poland, R. E., Lutchmansingh, P., McCracken, J. T., et al. (1997) Abnormal ACTH
and prolactin responses to fenfl uramine in rats exposed to single and multiple
doses of MDMA. Psychopharmacology 131, 411-419.
88. Gartside, S., McQuade, R., and Sharp, T. (1996) Effects of repeated administration
of 3,4-methylenedioxymethamphetamine on 5-hydroxytryptamine neuronal activ-
ity and release in the rat brain in vivo. J. Pharmacol. Exp. Ther. 279, 277-283.
89. Aguirre, N., Frechilla, D., García-Osta, A., Lasheras, B., and Del Río, J.
(1997) Differential regulation by methylenedioxymethamphetamine of
5-hydroxytryptamine 1A receptor density and mRNA expression in rat hippocam-
pus, frontal cortex, and brainstem: the role of corticosteroids. J. Neurochem. 68,
1099-1105.
90. Aguirre, N., Ballaz, S., Lasheras, B., and Del Río, J. (1998) MDMA ('Ecstasy')
enhances 5-HT 1A receptor density and 8-OH-DPAT-induced hypothermia: block-
ade by drugs preventing 5-hydroxytryptamine depletion. Eur. J. Pharmacol. 346,
181-188.
91. Wallace, T. L., Gudelsky, G., and Vorhees, C. V. (2001) Alterations in diurnal and
nocturnal locomotor activity in rats treated with a monoamine-depleting regimen of
methamphetamine or 3,4-methylenedioxymethamphetamine. Psychopharmacol-
ogy 153, 321-326.
92. Dafters, R. I. and Lynch, E. (1998) Persistent loss of thermoregulation in the rat
induced by 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) but not
by fenfl uramine. Psychopharmacology 138, 207-212.
93. Mechan, A. O., O'Shea, E., Elliott, J. M., Colado, M. I., and Green, A. R. (2001)
A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)
to rats results in a long term defect in thermoregulation. Psychopharmacology
155, 413-418.
94. Matuszewich, L., Filon, M. E., Finn, D. A., and Yamamoto, B. K. (2002)
Altered forebrain neurotransmitter responses to immobilization stress following
3,4-methylenedioxymethamphetamine. Neuroscience 110, 41-48.
95. Jones, B. E. (2000) Basic mechanisms of sleep-wake state, in Principles and
Practice of Sleep Medicine , 3rd ed. (Kryger, M. H., Roth, T., and Dement, W. C.,
eds.), W. B. Saunders, Philadelphia, pp. 134-154.
96. Morley, K. C., Gallate, J. E., Hunt, G. E., Mallet, P. E., and McGregor, I. S. (2001)
Increased anxiety and impaired memory in rats 3 months after administration